Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Redhill Biopharma Ltd. (RDHL) had Stock-Based Compensation of $0.30M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$8.57M |
|
$0.05M |
|
$17.70M |
|
$26.27M |
|
$25.56M |
|
-- |
|
$1.79M |
|
$27.35M |
|
$-1.08M |
|
$-6.37M |
|
$-1.08M |
|
-- |
|
| Cash Flow Statement Financials | |
$-4.56M |
|
$0.37M |
|
$5.38M |
|
$3.97M |
|
$5.16M |
|
$1.19M |
|
|
Stock-Based Compensation |
$0.30M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|